Month: May 2017

Medicines360 and Allergan Present Four-Year Multi-Center Pivotal Trial Data of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg at the 2017 ACOG Meeting

by admin

Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Medicines360, a nonprofit women’s health pharmaceutical company with a mission of expanding access to quality medicines, presented four-year data from their ongoing multi-center U.S.-based pivotal trial of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg at the American College of Obstetricians and Gynecologists (ACOG) annual clinical and scientific meeting.

  • Posted in Press Releases
  • Comments Off on Medicines360 and Allergan Present Four-Year Multi-Center Pivotal Trial Data of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg at the 2017 ACOG Meeting

[Journal of Obstetrics & Gynecology] Four-year efficacy and safety of the Liletta™ levonorgestrel intrauterine system

by admin

  • Posted in Publications
  • Comments Off on [Journal of Obstetrics & Gynecology] Four-year efficacy and safety of the Liletta™ levonorgestrel intrauterine system